Drug Delivery to the Lungs 2024
Drug Delivery to the Lungs (DDL) is a premier conference dedicated to pulmonary and nasal drug delivery and brings together leading scientists, academics, clinicians, regulators and industry experts. The focus is on providing a forum to present through podium and poster presentations recent developments in the field of inhalation therapy.
Date: December 11-13, 2024
Location: Edinburgh, Scotland
Booth: #205
JOIN US!
Catalent Inhalation has the capabilities, expertise, and state-of-the-art facilities to expedite product development, from concept and feasibility studies through commercial manufacture and release testing. Complete the form to schedule a meeting with the Catalent Inhalation team at DDL 2024 to discuss how we can partner and help bring your inhaled therapy to market, faster.
ABOUT CATALENT INHALATION
Catalent Inhalation has the capabilities, expertise, and state-of-the-art facilities to expedite product development, from concept and feasibility studies through commercial manufacture and release testing. With over 30 years of inhalation product experience, Catalent can handle the most complex projects and help bring therapies to market faster. Whether a single service or a comprehensive development package is required, Catalent offers end-to-end expertise in dry powders for inhalation (DPI), unit-dose liquid and powder, bi-dose and preserved multi-dose nasal sprays. Our DPI expertise lies in spray-dried or lactose blended powders for inhalation, encapsulation and blistering. In addition, Catalent provides comprehensive analytical, bioanalytical and clinical supply services.
